小胶质细胞中的信号转导衔接蛋白1(STAP1)促进胶质瘤恶性进展
本研究利用癌症基因组图谱和中国胶质瘤基因组图谱数据库分析STAP1 mRNA水平与胶质瘤临床参数的关系,并通过细胞实验和小鼠模型探究STAP1在小胶质细胞中的作用。结果显示,胶质瘤相关小胶质细胞中STAP1表达与恶性程度和不良预后正相关,STAP1可能通过增加ARG1表达促进M2样极化并抑制吞噬功能,是潜在治疗靶点。
要点
- 胶质瘤相关小胶质细胞中STAP1表达与恶性程度和不良预后正相关。
- STAP1可能通过增加ARG1表达促进小胶质细胞M2样极化。
- STAP1可能抑制小胶质细胞吞噬功能,与cofilin和丝状伪足减少相关。
核心结论
- STAP1与胶质瘤恶性程度正相关,可能成为胶质瘤潜在的新治疗靶点。
研究设计与样本
- 研究利用癌症基因组图谱和中国胶质瘤基因组图谱数据库分析STAP1 mRNA水平与临床参数(分级、异柠檬酸脱氢酶突变、总生存期)的关联。
- 采用RNA测序、qRT-PCR、蛋白质印迹、免疫组织化学和免疫荧光分析检测STAP1及相关蛋白表达水平。
- 使用BV-2细胞构建STAP1过表达细胞系,通过流式细胞术和荧光显微镜评估BV-2细胞的吞噬作用。
- 使用C57BL/6小鼠建立原位和皮下胶质瘤小鼠模型,通过生物发光成像监测胶质瘤生长。
主要发现
- 胶质瘤相关小胶质细胞中STAP1表达与胶质瘤恶性程度和不良预后正相关。
- STAP1可能通过增加ARG1表达促进M2样极化,并抑制小胶质细胞的吞噬作用。
- ARG1增加可能与IL-6/STAT3通路相关。
- 吞噬功能受损可能与cofilin和丝状伪足减少相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioma is the most malignant primary brain tumor with a poor survival time. The tumour microenvironment, especially glioma-associated microglia/macrophages (GAMs), plays an important role in the pathogenesis of glioma. Currently, microglia (CD11b+/CD45Low) and macrophages (CD11b+/CD45High) are distinguished as distinct cell types due to their different origins. Moreover, signal-transducing adaptor protein 1 (STAP1) plays a role in tumourigenesis and immune responses. However, to date, no studies have been reported on STAP1 in GAMs. METHODS: The Cancer Genome Atlas and Chinese Glioma Genome Atlas databases were used to investigate the association between STAP1 mRNA levels and clinical parameters (grades, mutations in isocitrate dehydrogenase, and overall survival). RNA-sequencing, qRT-PCR, Western blotting, immunohistochemistry and immunofluorescence analyses were performed to detect the expression level of STAP1 and related proteins. BV-2 cells were used to construct a STAP1-overexpressing cell line. Phagocytosis of BV-2 cells was assessed by flow cytometry and fluorescence microscopy. C57BL/6 mice were used to establish orthotopic and subcutaneous glioma mouse models. Glioma growth was monitored by bioluminescence imaging. RESULTS: STAP1 expression in glioma-associated microglia is positively correlated with the degree of malignancy and poor prognosis of glioma. Moreover, STAP1 may promote M2-like polarisation by increasing ARG1 expression and inhibiting microglial phagocytosis of microglia. Increased ARG1 may be associated with the IL-6/STAT3 pathway. Impaired phagocytosis may be associated with decreased cofilin and filopodia. CONCLUSION: STAP1 is positively associated with the degree of glioma malignancy and may represent a potential novel therapeutic target for glioma.
引用
- Yang X, Ji C, Qi Y, et al. Signal-transducing adaptor protein 1 (STAP1) in microglia promotes the malignant progression of glioma. J Neurooncol. 2023. PMID: 37462801. doi:10.1007/s11060-023-04390-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。